Background {#Sec1}
==========

Liver cancer is a common cancer in China, particularly in men and residents of rural areas \[[@CR1], [@CR2]\]. Postoperative recurrent hepatocellular carcinoma (HCC) presents a challenge for surgeons. Currently, radiofrequency ablation is an effective treatment for HCCs that are smaller than 3 cm \[[@CR3]--[@CR6]\]; transcatheter arterial chemoembolization (TACE) combined with computed tomography-guided percutaneous thermal ablation can also be used to treat these tumors \[[@CR7]\]. However, in most cases, radiofrequency ablation is contraindicated in patients with recurrent HCC because of large tumor size, severe peritoneal adhesions, or tumor location (at the surface of the liver and adjacent to large vessels). TACE is generally a non-radical treatment; repeat surgical resection is an effective radical treatment. In the past, open surgery was often performed, which had disadvantages such as a large incision, a complex surgical approach, and a slow recovery. The development of laparoscopic techniques has produced advances in the complete laparoscopic resection of recurrent HCC \[[@CR7]--[@CR9]\], and single-entry laparoscopic resection and radiofrequency ablation combined with laparoscopic resection of recurrent HCC have been reported \[[@CR10]\]. However, further research is needed to evaluate the treatment outcomes of these operations. We conducted a prospective study of 64 patients who underwent resection of recurrent HCC at our hospital between June 2014 and November 2014 and performed a comparative evaluation of laparoscopic resection and open surgery.

Methods {#Sec2}
=======

Patients and inclusion/exclusion criteria {#Sec3}
-----------------------------------------

The Institutional Review Board at Sun Yat-sen University Cancer Center approved this prospective study, and the methods were carried out in accordance with approved guidelines (ClinicalTrials.gov ID: NCT02613156).

The inclusion criteria were as follows: (1) recurrent HCC after open surgery; (2) recurrent HCC located in any part of the left lateral lobe or the diaphragm side of the right lobe and near the surface of the liver, without noteworthy surgical contraindications; (3) no major vessel or bile duct tumor invasion or metastasis; (4) grade A or B liver function or grade C liver function that recovered to grade A after liver-protective treatment; and (5) a signed informed consent form from the patient. The exclusion criteria were as follows: (1) major vessel or bile duct tumor invasion; (2) recurrent HCC located in the right liver parenchyma and near secondary vessels and bile ducts; (3) extrahepatic metastasis; (4) grade C liver function; (5) noteworthy surgical contraindications; or (6) patient refusal to undergo laparoscopic hepatectomy.

Observation indicators and detection methods {#Sec4}
--------------------------------------------

Routine biochemical tests were conducted as part of the postoperative re-examination, and changes in alanine aminotransferase and aspartate aminotransferase levels were used to assess postoperative liver function changes. The severity of adhesions was assessed using the modified American Fertility Society (mAFS) classification scoring system. Pain scores were evaluated using a visual analogue scale (VAS) after surgery (the 1st day). Patients were followed up every 2 or 3 months after discharge from the hospital.

Treatments {#Sec5}
----------

### Surgical instruments {#Sec6}

The surgical instruments used for patients in the laparoscopic group included conventional laparoscopic instruments (three 5-mm trocars, two 10-mm trocars, and two damage-free laparoscopic clamps), the STORZ high-resolution laparoscopic operating system (Mittelstra*ße*, Tuttlingen, Germany), the GEN300 ultrasonic scalpel system (Johnson and Johnson, New Brunswick, NJ, USA), a laparoscopic linear cutter stapler (Johnson and Johnson, New Brunswick, NJ, USA), a laparoscopic ultrasound device, LigaSure, bipolar coagulation, titanium laparoscopic clips, and absorbable hemostatic gauze.

The surgical instruments used for patients in the control group included conventional laparotomy instruments, an electric scalpel, an intraoperative B-mode ultrasound device, proline tubing, gelatin sponges, and absorbable hemostatic gauze.

### Surgical approaches {#Sec7}

All patients received general anesthesia and intubation. Based on the tumor location, patients in the laparoscopic group were placed in the supine position, with their legs spread apart or horizontally; patients in the control group were positioned horizontally. Moreover, in the laparoscopic group, if the tumor was in the right lobe, a five-way-access approach was used, in which the surgeon stood on the same side as the tumor, the laparoscope-supporting assistant stood between the patient's legs, and the surgical assistant stood on the other side of the tumor. A small incision (1.5 cm in diameter) was made along the upper navel edge, and a Veress needle was inserted to establish pneumoperitoneum. Next, a 10-mm trocar was inserted, and then the laparoscope was inserted to explore the liver tumor and peritoneal adhesions. Pressure was maintained at 8--12 mmHg. Next, a small incision (0.5 cm in diameter) was made 2 cm underneath the right costal margin, and a 5-mm trocar was inserted for auxiliary surgical access. Another small incision (1.0 cm in diameter) was made laterally and inferiorly, and a 10-mm trocar was inserted and used as the main surgical access. A small incision (0.5 cm in diameter) was then made underneath the left costal margin, and a 5-mm trocar was inserted for auxiliary surgical access. These access points were located as far away from the adhesions as possible. If it was impossible to circumvent peritoneal adhesions, laparoscopic separation of the adhesions was performed first. If the tumor was in the S2 or S3 segment, a four-way-access approach was used: the surgeon stood on the right side of the patient, and the first assistant stood on the left side of the patient. Only one access point underneath the left costal margin was required. During resection of tumor lesions and liver segments from the right lobe, the surgeon separated adhesions in the operating field that were near the abdominal wall using an ultrasonic scalpel and then determined the location and incision edges of the tumor under the guidance of laparoscopic ultrasound. Next, the surgeon used an ultrasound-guided scalpel to separate the liver parenchyma, followed by the use of LigaSure coagulation to stop bleeding from small vessels. Groups of titanium clips were used to stop the bleeding if the LigaSure coagulation was ineffective. The surgeon resected the tumor after separating the liver parenchyma. If the tumor was in the S2 or S3 segment, the surgeon performed laparoscopic resection of the left lateral lobe. After separating the adhesions, the surgeon cut the left coronary ligament and the left triangular ligament. The assistant pulled the left lobe upward and to the right, and the surgeon separated the hepatogastric ligament and verified that the incision edge was more than 2 cm away from the tumor (guided by laparoscopic ultrasound). Next, the surgeon separated the liver parenchyma along the incisions on the surface of the liver until reaching the vascular pedicle of the S2 and S3 segments and then used a laparoscopic linear cutter stapler to cut the residual liver tissue and vessels to resect the left lobe. A gelatin sponge was used to stop minor bleeding in the operating field. After the wound was checked for active bleeding, the surgeon expanded the incision at the navel edges to remove the specimen. Next, the surgeon placed an abdominal drainage tube according to standard procedures. For patients in the control group, if the tumor was in the left lateral lobe or the right anterior lobe, an incision was made along the midline of the abdominal wall; if the tumor was in the right lobe, an oblique incision was made underneath and along the costal margin. Adhesions were separated after the abdominal wall was opened, and intraoperative B-mode ultrasound was used to determine the location of the tumor and incision lines. A conventional surgical approach was used for local resection or segmental resection of the HCC. If the tumor was in the S2 or S3 segment, the left lateral lobe was resected with an open lobectomy, and an abdominal drainage tube was placed according to standard procedures.

Statistical analysis {#Sec8}
--------------------

SPSS 21.0 software was used to process all data. Measurement data are expressed as the mean ± standard deviation and were analyzed with an independent-sample *t* test. Count data were analyzed with the *χ*^2^ test. Relapse-free survival was analyzed using the Kaplan--Meier method. *P* \< 0.05 were considered statistically significant.

Results {#Sec9}
=======

Study population and baseline clinical characteristics {#Sec10}
------------------------------------------------------

We studied 64 patients who underwent resection of recurrent HCC at our hospital between June 2014 and November 2014. The laparoscopic group comprised 31 patients who underwent laparoscopic resection of the recurrent HCC; the control group comprised 33 patients who underwent conventional open surgery. Case grouping was decided by a multidisciplinary team. In the laparoscopic group, 26 patients were men and 5 patients were women (age range, 37--66 years; median, 54 years); the recurrent tumors had an average size of 2.5 ± 1.0 cm. In the control group, 27 patients were men and 6 patients were women (age range, 34--65 years; median, 59.5 years); the recurrent tumors had an average size of 3.8 ± 1.1 cm. The hepatic falciform ligament comprised the border between the left lateral lobe (to the left) and the right lobe (to the right). Detailed clinical data of the two groups of patients are shown in Table [1](#Tab1){ref-type="table"}. No significant difference was observed between the two groups of patients in their general information before the operation.Table 1Baseline characteristics of all enrolled patientsCharacteristicLaparoscopic groupOpen surgery group (control)*P* valueSex (cases)0.904 Men2627 Women56Age (years)0.413 Median5459.5 Range37--6634--65BMI0.912 Median24.425.0 Range19.1--31.021.8--29.9Initial surgical lesion site (cases)0.665 Right lobe2225 Left lobe98Primary tumor size (cm)4.1 ± 1.54.9 ± 2.60.382Time to recurrence (months)28.4 ± 27.727.5 ± 16.30.282Size of recurrent tumor (cm)2.5 ± 1.03.8 ± 1.10.45Recurrent site (cases)0.632 Right lobe1619 Left lobe1514Operation method (cases)0.955 Left lateral lobectomy1213 Local resection1920Total bilirubin (μmol/L)31.2 ± 7.433.7 ± 10.40.742Albumin (g/L)35.2 ± 3.336.4 ± 4.30.532ALT (U/L)49.6 ± 6.476.3 ± 7.50.671AST (U/L)52.4 ± 7.469.4 ± 8.40.832Prothrombin time (s)11.5 ± 0.712.4 ± 1.00.651AFP (cases)0.264 \>400 ng/mL2724 \<400 ng/mL49HBV-DNA (log10 IU/mL)3.50 ± 0.83.0 ± 0.20.192*BMI* body mass index, *ALT* alanine aminotransferase, *AST* aspartate aminotransferase, *AFP* α-fetoprotein, *HBV* hepatitis B virus

There were 53 men and 11 women patients, with a median age of 52.5 years (range, 45--74 years). Except for hepatectomy, 9, 5, and 2 patients underwent further TACE, local thermal ablation, and sorafenib treatment, respectively, before this study. The mean baseline characteristics were similar between the two groups. The median follow-up period for all patients was 17 months (range, 12--18 months); the median survival time was 11.0 months (95% confidence interval 9.2--15.9 months).

Efficacy of complete laparoscopic resection {#Sec11}
-------------------------------------------

All operations were successfully completed, and none of the patients in the laparoscopic group required conversion to open surgery. Moreover, no serious postoperative complications were observed in either group. Significant differences were observed between the laparoscopic and control groups in operation time (116.7 ± 37.5 vs. 148.2 ± 46.7 min, *P* = 0.031), intraoperative blood loss (117.5 ± 35.5 vs. 265.9 ± 70.3 mL, *P* = 0.012), postoperative time until the patient could walk (1.6 ± 0.6 vs. 2.2 ± 0.8 days, *P* = 0.004), anal exsufflation time (2.1 ± 0.3 vs. 2.8 ± 0.7 days, *P* = 0.041), VAS scores (*P* \< 0.001), postoperative hepatic function (*P* \< 0.05), and length of hospital stay (4.5 ± 1.3 vs. 6.0 ± 1.2 days, *P* = 0.014). In contrast, no differences between the two groups were observed in surgical margins, grade of peritoneal adhesions, or inpatient costs (Table [2](#Tab2){ref-type="table"}).Table 2Comparison of perioperative conditions between the laparoscopic and control groupsCharacteristicLaparoscopic groupOpen surgery group*P* valueOperation time (min)116.7 ± 37.5148.2 ± 46.70.031Surgical margin (cm)2.1 ± 1.22.2 ± 0.60.068Intraoperative blood loss (mL)117.5 ± 35.5265.9 ± 70.30.012Grade of peritoneal adhesions (cases)0.880 11820 286 334 423VAS score (cases)\<0.001 0--3209 4--6818 7--1036ALT (U/L)^a^179.6 ± 17.4312.3 ± 28.20.012AST (U/L)^a^84.1 ± 16.1223.4 ± 30.10.029Anal exsufflation time (days)2.1 ± 0.32.8 ± 0.70.041Postoperative time until the patient could walk (days)1.6 ± 0.62.2 ± 0.80.004Hospital stay (days)4.5 ± 1.36.0 ± 1.20.014Inpatient costs (×10,000 yuan)6.3 ± 0.45.5 ± 0.60.079Postoperative recurrence \[cases (%)\]5 (16.1)7 (21.2)0.603*VAS* visual analogue scale, *BMI* body mass index, *ALT* alanine aminotransferase, *AST* aspartate aminotransferase, *AFP* α-fetoprotein, *HBV* hepatitis B virus^a^ALT and AST were tested on the 3rd day after surgery

Comparison of patients with contralateral and ipsilateral recurrence after laparoscopic hepatectomy {#Sec12}
---------------------------------------------------------------------------------------------------

Moreover, we compared the data for patients in the laparoscopic group with contralateral or ipsilateral recurrence (18 and 13 patients, respectively, based on the initial operation). Interestingly, compared with patients with ipsilateral recurrence, patients with contralateral recurrence tended to have less intraoperative blood loss (97.7 ± 14.0 vs. 186.3 ± 125.6 mL, *P* = 0.012) and a shorter hospital stay (4.2 ± 0.7 vs. 6.1 ± 1.7 days, *P* = 0.021) (Table [3](#Tab3){ref-type="table"}).Table 3Comparison of patients with contralateral and ipsilateral recurrence after laparoscopic hepatectomyCharacteristicContralateral recurrence (*n* = 18)Ipsilateral recurrence (*n* = 13)*P* value*T*/*χ* ^2^Recurrent tumor size (cm)4.4 ± 0.93.7 ± 1.40.2271.3Operation time (min)112.4 ± 18.6159.4 ± 39.00.034−0.6Surgical margin (cm)3.6 ± 1.02.1 ± 0.60.166−0.3Intraoperative blood loss (mL)97.7 ± 14.0186.3 ± 125.60.012−2.1Postoperative time until the patient could walk (days)1.8 ± 0.51.6 ± 0.50.478−0.5Anal exsufflation time (days)2.3 ± 0.52.1 ± 0.70.634−0.2Hospital stay (days)4.2 ± 0.76.1 ± 1.70.021−2.1Inpatient costs (×10,000 yuan)6.2 ± 0.35.8 ± 0.70.575−0.6

Short-term effect of laparoscopic hepatectomy on recurrent HCC {#Sec13}
--------------------------------------------------------------

During the 1-year postoperative follow-up period, 5 patients (16.1%) in the laparoscopic group and 7 patients (21.2%) in the control group relapsed, although no significant difference was observed in relapse-free survival between the two groups (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Kaplan--Meier *curves* showing relapse-free survival (RFS) for all 64 patients with hepatocellular carcinoma. No significant difference in RFS was observed between the laparoscopic group and the open surgery (control) group

Discussion {#Sec14}
==========

Based on the results of this study, we propose that laparoscopic resection of recurrent HCC is feasible for patients who previously underwent conventional open surgery. Compared with conventional open surgery, complete laparoscopic resection of recurrent HCC has the advantages of a shorter operation time, less intraoperative blood loss, and less pain, resulting in a faster postoperative recovery and a shorter hospital stay.

Since Reich et al. \[[@CR11]\] reported the first successful laparoscopic liver resection in 1991, the use of laparoscopy for liver resection has gradually increased. Additionally, laparoscopic liver surgery has become increasingly common as laparoscopic surgical instruments have improved and surgeons have gained more experience \[[@CR12]--[@CR16]\]. Several studies have reported laparoscopic resection of the caudate lobe and complete laparoscopic resection combined with associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) \[[@CR17]--[@CR20]\]. Moreover, pilot studies have confirmed the feasibility and value of complete laparoscopic ALPPS, and ALPPS has been used to remove donor livers during liver transplantation \[[@CR21]--[@CR24]\].

Generally, because of the complexity of postoperative adhesion, laparoscopic surgery is not recommended for repeat surgery, and there have been only a few reports on this approach. Kanazawa et al. \[[@CR8]\] and Chan et al. \[[@CR9]\] reported their results for laparoscopic resection of recurrent HCC; they found that patients in the laparoscopic group had significantly less intraoperative blood loss than patients in the open surgery group, which was consistent with the results of our study. In addition, we found that, regarding operation time, postoperative time until the patient could walk, postoperative pain, and length of hospital stay, laparoscopic resection was superior to open surgery. Patients in the laparoscopic group had a shorter operation time for the following reasons: (1) once pneumoperitoneum was established under laparoscopic guidance, the increase in pressure increased the tension of adhesions, which, together with a large laparoscopic operating field, facilitated the separation of the adhesions; (2) certain adhesions in non-operating fields could be circumvented by laparoscopic instruments and thus required no separation, resulting in no effect on exposure or the operation; and (3) during resection of the left lateral lobe, a cutting and closure device was typically used, eliminating the need to separate segmental vessels, thereby greatly reducing the operation time and bleeding. Moreover, the pressure of the pneumoperitoneum itself played a role in hemostasis. Intestinal adhesions were observed in both the laparoscopic group and the control group. The adhesions were rated as 4 or lower (according to the mAFS scoring system), and no extremely severe adhesions (5 or higher) were observed in this study, which highlighted the advantages of using a laparoscope, aided by large operating fields and the pressure produced by pneumoperitoneum, to separate mild to moderate adhesions. Patients who underwent laparoscopic resection of recurrent HCC had significantly lower postoperative pain scores, mainly because of markedly less nerve damage to the abdominal wall due to the use of smaller access points than those used for conventional large incisions. Moreover, because laparoscopic resection caused fewer injuries than open surgery, the patients could walk sooner, and their bowel functions recovered faster after the operation, thereby shortening the hospital stay. Nevertheless, no significant difference in inpatient costs was observed between the two groups.

During the 1-year follow-up period, no patients in either group died. Six patients in each group had recurrent HCC on the same side as the initial operation and underwent interventional treatment or radiofrequency ablation. No significant difference was observed in relapse-free survival between the two groups. A subgroup analysis of patients who underwent laparoscopic resection showed that intraoperative blood loss was significantly less and the hospital stay was significantly shorter for patients who had contralateral recurrence than for patients who had ipsilateral recurrence. For patients who had contralateral recurrence, milder adhesions in the operating field helped to reduce bleeding during the separation of peritoneal adhesions, thereby shortening the operation time, accelerating postoperative recovery, and highlighting the advantages of laparoscopic resection.

Conclusions {#Sec15}
===========

We found that laparoscopic resection of HCC is more effective than open surgery, and we recommend that it may be more widely used in clinical practice, even in cases of recurrent HCC. Complete laparoscopic resection is especially advantageous for recurrent lesions near the surface of the liver, such as the edges of the contralateral lobe, left lobe, and right lobe, and may be used as the preferred treatment. However, this was a non-randomized study, and a randomized controlled study with a large sample size is needed to confirm our results.
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